Company Filing History:
Years Active: 2023-2025
Title: Kevin Howe: Innovator in Pharmaceutical Composition
Introduction
Kevin Howe is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of compositions aimed at treating various gastrointestinal disorders. With a total of four patents to his name, Howe's work is recognized for its innovative approaches to healthcare.
Latest Patents
Among his latest patents, one includes a method of formulating a pharmaceutical composition that involves administering an immune modulator to the small intestine. This patent focuses on methods and compositions for treating inflammatory disorders or conditions that arise in tissues originating from the endoderm using an immune modulator. Another significant patent addresses the treatment of diseases of the gastrointestinal tract with a JAK or other kinase inhibitor, showcasing methods and compositions designed to tackle these specific health issues.
Career Highlights
Kevin Howe is currently associated with Biora Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes in gastrointestinal health.
Collaborations
Throughout his career, Howe has collaborated with notable colleagues, including Mitchell Lawrence Jones and Christopher Loren Wahl. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Kevin Howe stands out as a dedicated inventor in the pharmaceutical industry, with a focus on innovative treatments for gastrointestinal disorders. His contributions through patents and collaborations reflect his commitment to improving healthcare solutions.